- Home
- BME vs SENS Comparison
BME vs SENS Comparison
Compare BME & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BME
- SENS
- Stock Information
- Founded
- BME 2005
- SENS 1996
- Country
- BME United States
- SENS United States
- Employees
- BME N/A
- SENS N/A
- Industry
- BME Trusts Except Educational Religious and Charitable
- SENS Industrial Machinery/Components
- Sector
- BME Finance
- SENS Industrials
- Exchange
- BME Nasdaq
- SENS Nasdaq
- Market Cap
- BME 462.3M
- SENS 384.7M
- IPO Year
- BME N/A
- SENS N/A
- Fundamental
- Price
- BME $36.25
- SENS $0.73
- Analyst Decision
- BME
- SENS Strong Buy
- Analyst Count
- BME 0
- SENS 2
- Target Price
- BME N/A
- SENS $2.00
- AVG Volume (30 Days)
- BME 34.0K
- SENS 3.3M
- Earning Date
- BME 01-01-0001
- SENS 05-12-2025
- Dividend Yield
- BME 6.26%
- SENS N/A
- EPS Growth
- BME N/A
- SENS N/A
- EPS
- BME 1.44
- SENS N/A
- Revenue
- BME N/A
- SENS $22,472,000.00
- Revenue This Year
- BME N/A
- SENS $58.74
- Revenue Next Year
- BME N/A
- SENS $33.51
- P/E Ratio
- BME $28.37
- SENS N/A
- Revenue Growth
- BME N/A
- SENS 0.37
- 52 Week Low
- BME $35.53
- SENS $0.25
- 52 Week High
- BME $43.20
- SENS $1.40
- Technical
- Relative Strength Index (RSI)
- BME 43.29
- SENS 59.26
- Support Level
- BME $35.28
- SENS $0.58
- Resistance Level
- BME $36.65
- SENS $0.63
- Average True Range (ATR)
- BME 1.13
- SENS 0.06
- MACD
- BME 0.06
- SENS 0.02
- Stochastic Oscillator
- BME 46.83
- SENS 90.64
About BME Blackrock Health Sciences Trust
Blackrock Health Sciences Trust has an investment objective to provide total return through a combination of current income, current gains, and long-term capital appreciation. The Fund invests 80% of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.